A minimum weight gain, and no weight loss, is currently recommended for all pregnant women, including those who are already overweight or obese, due to the obligatory weight gain that occurs in maternal tissues during pregnancy with chronic malabsorption syndrome with cholestasis with known hypersensitivity to Orlistat or to any component of this product Warnings and Precautions: Orlistat may interact with concomitant drugs including cyclosporine, levothyroxine, warfarin, amiodarone, antiepileptic drugs, and antiretroviral drugs Orlistat can decrease cyclosporine exposure
Ideal candidates typically include adults over 30 experiencing difficulty losing abdominal fat, individuals who have plateaued in their weight loss journey, and those seeking to optimize body composition without the risks associated with full growth hormone therapy
Do GLP-1 Medications Cause Gas and Bloating
What the Human Trial Record Shows This compound has a documented history in human clinical research that distinguishes it from the vast majority of synthetic research peptides, which have never been tested in human subjects